ED LABORATORIES

ED Laboratories is an early-stage biotechnology company whose near-term focus is the development of novel and proprietary products that treat: a) glioblastomas, and b) retinoblastomas. Longer term, the company is focused on the development of novel cancer agents for the treatment of other types of tumors... ED Laboratories is dedicated to the discovery, development, and commercialization of its small-molecule technology to bring about life-changing therapeutics for mankind... ED Laboratories, Inc., (EDL) is an early stage company formed around novel and proprietary small-molecule technology developed at the University of Tennessee Health Science Center (UTHSC) in Memphis and licensed from the University of Tennessee Research Foundation (UTRF).

Also known as: ED Laboratories, Inc.

Primary location: Johnson City United States